Literature DB >> 24095882

Cochrane re-arranged: support for policies to vaccinate elderly people against influenza.

Walter E P Beyer1, Janet McElhaney, Derek J Smith, Arnold S Monto, Jonathan S Nguyen-Van-Tam, Albert D M E Osterhaus.   

Abstract

The 2010 Cochrane review on efficacy, effectiveness and safety of influenza vaccination in the elderly by Jefferson et al. covering dozens of clinical studies over a period of four decades, confirmed vaccine safety, but found no convincing evidence for vaccine effectiveness (VE) against disease thus challenging the ongoing efforts to vaccinate the elderly. However, the Cochrane review analyzed and presented the data in a way that may itself have hampered the desired separation of real vaccine benefits from inevitable 'background noise'. The data are arranged in more than one hundred stand-alone meta-analyses, according to various vaccine types, study designs, populations, and outcome case definitions, and then further subdivided according to virus circulation and antigenic match. In this way, general vaccine effects could not be separated from an abundance of environmental and operational, non vaccine-related variation. Furthermore, expected impacts of changing virus circulation and antigenic drift on VE could not be demonstrated. We re-arranged the very same data according to a biological and conceptual framework based on the basic sequence of events throughout the 'patient journey' (exposure, infection, clinical outcome, observation) and using broad outcome definitions and simple frequency distributions of VE values. This approach produced meaningful predictions for VE against influenza-related fatal and non-fatal complications (average ~30% with large dispersion), typical influenza-like illness (~40%), disease with confirmed virus infection (~50%), and biological vaccine efficacy against infection (~60%), under conditions of virus circulation. We could also demonstrate a VE average around zero in the absence of virus circulation, and decreasing VE values with decreasing virus circulation and increasing antigenic drift. We regard these findings as substantial evidence for the ability of influenza vaccine to reduce the risk of influenza infection and influenza-related disease and death in the elderly.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Effectiveness; Efficacy; Elderly; Influenza; Safety; Vaccination

Mesh:

Substances:

Year:  2013        PMID: 24095882     DOI: 10.1016/j.vaccine.2013.09.063

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  69 in total

1.  Estimating the Effect of Influenza Vaccination on Nursing Home Residents' Morbidity and Mortality.

Authors:  Aurora Pop-Vicas; Momotazur Rahman; Pedro L Gozalo; Stefan Gravenstein; Vincent Mor
Journal:  J Am Geriatr Soc       Date:  2015-08-17       Impact factor: 5.562

2.  Influenza vaccination and the end of simplicity.

Authors:  Thomas Mertens
Journal:  Dtsch Arztebl Int       Date:  2013-11-22       Impact factor: 5.594

3.  Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities.

Authors:  David A Nace; Chyongchiou Jeng Lin; Ted M Ross; Stacey Saracco; Roberta M Churilla; Richard K Zimmerman
Journal:  J Infect Dis       Date:  2014-12-17       Impact factor: 5.226

4.  Use of neuraminidase inhibitors in primary health care during pandemic and seasonal influenza between 2009 and 2013.

Authors:  Thierry Blanchon; Félicité Geffrier; Clément Turbelin; Isabelle Daviaud; Cédric Laouénan; Xavier Duval; Bruno Lambert; Thomas Hanslik; Anne Mosnier; Catherine Leport
Journal:  Antivir Ther       Date:  2015-02-17

Review 5.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

6.  Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence.

Authors:  Ilaria Loperto; Andrea Simonetti; Antonio Nardone; Maria Triassi
Journal:  Hum Vaccin Immunother       Date:  2019-03-25       Impact factor: 3.452

7.  Establishment of a cohort for deep phenotyping of the immune response to influenza vaccination among elderly individuals recruited from the general population.

Authors:  Manas K Akmatov; Peggy Riese; Marcus May; Leonhard Jentsch; Malik W Ahmed; Damaris Werner; Anja Rösel; Megan Tyler; Kevin Pessler; Jana Prokein; Inga Bernemann; Norman Klopp; Blair Prochnow; Stephanie Trittel; Aravind Tallam; Thomas Illig; Christoph Schindler; Carlos A Guzmán; Frank Pessler
Journal:  Hum Vaccin Immunother       Date:  2017-04-10       Impact factor: 3.452

Review 8.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

Review 9.  Influenza vaccination: a summary of Cochrane Reviews.

Authors:  S F Østerhus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-09-04       Impact factor: 3.267

10.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.